Skip to main content
TipRanks
Go Ultimate75% OFF

David Madden Insider Profile

4 Followers

David Madden, former Director at Dicerna Pharma, holds 232.52K shares in Dicerna Pharma (Ticker: DRNA). Most recently, David Madden Bought 222,511 shares of Dicerna Pharma on Feb 20, 2014 for an estimated value of $384.79K.

David Madden's Trading History

DRNA
Dicerna Pharma
Feb 20, 2014―Informative Buy384.79K$8.89M
DRNA
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Feb 20, 2014Informative Buy$112.50K7,500$15.00-33.80%
Feb 20, 2014Informative Buy$384.79K222,511$1.72-33.80%
Jan 29, 2014Uninformative Buy―112,511$46.00―

You May Also Like

David Madden insider profile FAQ

What is the percentage of profitable transactions made by David Madden?
The percentage of profitable transactions made by David Madden is 0%.
What is the average return per transaction made by David Madden?
The average return per transaction made by David Madden is -33.80%.
What stocks does David Madden hold?
David Madden holds: DRNA stocks.
What was David Madden’s latest transaction?
David Madden’s latest transaction was an Informative Buy of $384.79K.
What was David Madden's most profitable transaction?
David Madden’s most profitable transaction was an Informative Buy of DRNA stock on February 20, 2014. The return on the trade was -33.80%.
What is David Madden's role in Dicerna Pharma?
David Madden's role in Dicerna Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.